DB Wealth Management Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$10.3K Hold
65
0.01% 284
2023
Q3
$9.51K Hold
65
0.01% 283
2023
Q2
$9.95K Hold
65
0.01% 283
2023
Q1
$10.1K Hold
65
0.01% 279
2022
Q4
$10K Buy
+65
New +$9.59K 0.01% 277
2021
Q2
Sell
-23
Closed -$4K 356
2021
Q1
$4K Hold
23
﹤0.01% 313
2020
Q4
$4K Buy
+23
New +$3.73K ﹤0.01% 311

Other funds holding FBT

DB Wealth Management Group's FBT Position: Q4 2023 in Review

DB Wealth Management Group held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q4 2023 at 65 shares worth $10.3K. The position accounts for 0.01% of the portfolio, ranked #284.

DB Wealth Management Group first reported a position in FBT in Q4 2020 and has held it in 7 quarters since. 257 funds tracked by Wall St. Rank hold FBT as of Q4 2023.

  • DB Wealth Management Group held 65 shares of First Trust NYSE Arca Biotechnology Index Fund worth $10.3K as of Q4 2023.
  • DB Wealth Management Group left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q4 2023.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of DB Wealth Management Group's portfolio in Q4 2023, its #284 holding.
  • DB Wealth Management Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2020 and has held it in 7 quarters since.
  • 257 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2023.

Based on DB Wealth Management Group's 13F filing for Q4 2023, filed 9 Jan 2024.